Immunome, Inc. (IMNM)
19.08
-0.22
(-1.17%)
USD |
NASDAQ |
Oct 07, 16:00
19.08
0.00 (0.00%)
After-Hours: 20:00
Immunome Total Liabilities (Quarterly) : 40.30M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.30M |
| March 31, 2026 | 31.11M |
| December 31, 2025 | 48.84M |
| September 30, 2025 | 35.46M |
| June 30, 2025 | 27.02M |
| March 31, 2025 | 35.57M |
| December 31, 2024 | 59.08M |
| September 30, 2024 | 41.99M |
| June 30, 2024 | 42.38M |
| March 31, 2024 | 34.18M |
| December 31, 2023 | 28.66M |
| September 30, 2023 | 87.08M |
| Date | Value |
|---|---|
| June 30, 2023 | 32.10M |
| March 31, 2023 | 34.25M |
| December 31, 2022 | 7.393M |
| September 30, 2022 | 7.462M |
| June 30, 2022 | 8.742M |
| March 31, 2022 | 9.854M |
| December 31, 2021 | 9.74M |
| September 30, 2021 | 7.765M |
| June 30, 2021 | 3.524M |
| March 31, 2021 | 4.71M |
| December 31, 2020 | 3.18M |
| September 30, 2020 | 61.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Erasca, Inc. | 73.18M |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 565.38M |
| Shareholders Equity (Quarterly) | 525.08M |
| Debt to Equity Ratio | 0.009 |
| Current Ratio | 15.08 |
| Net Debt Paydown Yield | 0.00% |